Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Xiao-Xue Yao"'
Autor:
Qu-Jing Gai, Zhen Fu, Jiang He, Min Mao, Xiao-Xue Yao, Yan Qin, Xi Lan, Lin Zhang, Jing-Ya Miao, Yan-Xia Wang, Jiang Zhu, Fei-Cheng Yang, Hui-Min Lu, Ze-Xuan Yan, Fang-Lin Chen, Yu Shi, Yi-Fang Ping, You-Hong Cui, Xia Zhang, Xindong Liu, Xiao-Hong Yao, Sheng-Qing Lv, Xiu-Wu Bian, Yan Wang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-12 (2022)
Abstract Platelet-derived growth subunit A (PDGFA) plays critical roles in development of glioblastoma (GBM) with substantial evidence from TCGA database analyses and in vivo mouse models. So far, only platelet-derived growth receptor α (PDGFRA) has
Externí odkaz:
https://doaj.org/article/405264fc1e9d490c8dafcef11c97de0f
Autor:
Yue‐Liang Yao, Yan‐Xia Wang, Fei‐Cheng Yang, Chuan Wang, Min Mao, Qu‐Jing Gai, Jiang He, Yan Qin, Xiao‐Xue Yao, Xi Lan, Jiang Zhu, Hui‐Min Lu, Hui Zeng, Xiao‐Hong Yao, Xiu‐Wu Bian, Yan Wang
Publikováno v:
CNS Neuroscience & Therapeutics. 28:1033-1044
Sonic hedgehog subtype medulloblastoma is featured with overactivation of hedgehog pathway and can be targeted by SMO-specific inhibitors. However, the resistance is frequently developed leading to treatment failure of SMO inhibitors. W535L mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60478a69df89b1449b6a7c1994785d34
https://doi.org/10.1111/cns.13835
https://doi.org/10.1111/cns.13835
Autor:
Fei-Cheng Yang, Chuan Wang, Jiang Zhu, Qu-Jing Gai, Min Mao, Jiang He, Yan Qin, Xiao-Xue Yao, Yan-Xia Wang, Hui-Min Lu, Mian-Fu Cao, Ming-Min He, Xian-Mei Wen, Ping Leng, Xiong-Wei Cai, Xiao-Hong Yao, Xiu-Wu Bian, Yan Wang
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 102(7)
Invasive growth of glioblastoma makes residual tumor unremovable by surgery and leads to disease relapse. Temozolomide is widely used first-line chemotherapy drug to treat glioma patients, but development of temozolomide resistance is almost inevitab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe4ed85aefab8e79129ce179f90a3fa7
https://pubmed.ncbi.nlm.nih.gov/35351965
https://pubmed.ncbi.nlm.nih.gov/35351965
Autor:
Sheng-Qing Lv, Zhen Fu, Lin Yang, Qing-Rui Li, Jiang Zhu, Qu-Jing Gai, Min Mao, Jiang He, Yan Qin, Xiao-Xue Yao, Xi Lan, Yan-Xia Wang, Hui-Min Lu, Yan Xiang, Zuo-Xin Zhang, Guo-Hao Huang, Wei Yang, Ping Kang, Zhijian Sun, Yu Shi, Xiao-Hong Yao, Xiu-Wu Bian, Yan Wang
Publikováno v:
Theranostics
Rationale: Around 10%-20% patients with glioblastoma (GBM) are diagnosed with more than one tumor lesions or multifocal GBM (mGBM). However, the understanding on genetic, DNA methylomic, and transcriptomic characteristics of mGBM is still limited. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::807296691d218562a8ebaabba8f3f346
https://pubmed.ncbi.nlm.nih.gov/34987659
https://pubmed.ncbi.nlm.nih.gov/34987659
Autor:
Sheng-Qing Lv, Zhen Fu, Lin Yang, Qing-Rui Li, Jiang Zhu, Qu-Jing Gai, Min Mao, Jiang He, Yan Qin, Xiao-Xue Yao, Xi Lan, Yan-Xia Wang, Hui-Min Lu, Yan Xiang, Zuo-Xin Zhang, Guo-Hao Huang, Wei Yang, Ping Kang, Zhijian Sun, Yu Shi
Publikováno v:
Theranostics; 2022, Vol. 12 Issue 1, p459-473, 15p